Article
Genotype-defined cancer risk in juvenile polyposis syndrome.
The British journal of surgery - 1 Jan 2015
Aytac E, Sulu B, Heald B, O'Malley M, LaGuardia L, Remzi F H, Kalady M F, Burke C A, Church J M
Abstract excerpt
BACKGROUND: Germline mutations in SMAD4 and BMPR1A disrupt the transforming growth factor β signal transduction pathway, and are associated with juvenile polyposis syndrome. The effect of genotype on the pattern of disease in this syndrome is unknown. This study evaluated the differential impact of SMAD4 and BMPR1A gene mutations on cancer risk and oncological phenotype in patients with juvenile polyposis...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
